Leerink Partnrs Lowers Earnings Estimates for Kura Oncology
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Analysts at Leerink Partnrs lowered their Q3 2025 earnings per share (EPS) estimates for shares of Kura Oncology in a research report issued to clients and investors on Wednesday, May 14th. Leerink Partnrs analyst J. Chang now anticipates that the company will post earnings of $0.15 per […]
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Analysts at Leerink Partnrs lowered their Q3 2025 earnings per share (EPS) estimates for shares of Kura Oncology in a research report issued to clients and investors on Wednesday, May 14th. Leerink Partnrs analyst J. Chang now anticipates that the company will post earnings of $0.15 per […]
